Flu-like sickness usually includes a fever of at least 100°F (37.8°C) and a cough or sore throat.3 It is estimated that the average number of symptomatic cases in the US is 33 million/year.4
Flu-like sickness is common and can be severe. Even with the costs of hospitalization excluded, flu-like sickness places a substantial burden on families, societies, and economies due to the costs associated with visiting the doctor’s office, medicine prescriptions, and loss of productivity in the workplace.5
In clinical studies, daily intake of LGG® has been associated with a significant effect on:
• The number of children with upper respiratory tract infections11
• The number of respiratory tract infections lasting more than three days10, 11
• How long respiratory symptoms last11
• The number of digestive system issues lasting more than two days10
Also, healthy children supplemented with LGG® had significantly fewer days away from daycare due to illness, compared to the placebo group.11 Read more about LGG® and probiotics and respiratory health
A similar effect was seen in adults.9 Healthy college students who received a combination of the LGG® and BB-12® probiotic strains for 12 weeks had 33% fewer days with symptoms of respiratory tract infection. Their symptoms were also less severe than those who received a placebo.9 Read more about BB-12® and supporting immune health with probiotics
The studies discussed suggest that if everyone living in America consumed probiotics, the incidence and costs of flu-like sickness would be significantly reduced. Therefore, supplementing with probiotics may not only be beneficial to health9, 10, 11, 12 but might also reduce the impact that flu-like sickness has on families, economies, and societies.1
Read more about probiotics for supporting immune health.
LGG® and BB-12® are registered trademarks of Chr. Hansen A/S.
The article is provided for informational purposes regarding probiotics and is not meant to suggest that any substance referenced in the article is intended to diagnose, cure, mitigate, treat, or prevent any disease.
Lactobacillus rhamnosus, LGG® is the world’s most documented probiotic strain. The LGG® strain has proven benefits across all ages and numerous health areas, including gastrointestinal, immune and oral health.
LGG® is a registered trademark of Chr. Hansen A/S
The probiotic strain Bifidobacterium, BB-12® is the world’s most documented probiotic bifidobacterium. It has been extensively studied and has been associated with improved outcomes across various health areas.
BB-12® is a registered trademark of Chr. Hansen A/S